India police bust racket of fake life-saving drugs under label of top brands The counterfeit drug ring operated through an extensive network spanning multiple Indian states The Independent UK · Aug 7, 2025
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga · Aug 1, 2025
Johnson & Johnson Stock: Analyst Estimates & Ratings Johnson & Johnson has outpaced the broader market and the healthcare sector in 2025, and analysts remain optimistic about the stock’s prospects. Barchart · Aug 1, 2025
Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Costs: Report The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted access. Benzinga · Jul 29, 2025
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs On July 8, US President Donald Trump shook the biopharmaceutical sector by announcing a tariff of up to 200% on pharmaceuticals, which would take effect “very soon.” 80% of prescription drugs sold in the US are made abroad, a statistic the President wants to flip on its head. Benzinga · Jul 25, 2025
2 Recession-Proof Dividend Stocks to Buy for the Second Half of 2025 These blue-chip stocks offer a rare combination of stability, resilience, and moderate growth. Barchart · Jul 23, 2025
4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise With solid Q2 results and 2025 guidance increases, Wall Street is upgrading these four stocks. Analysts now see palpable upside in one streaming stalwart. MarketBeat · Jul 23, 2025
10 Brand Names That Are Actually Owned By the Same Company Ever feel like you’re making diverse choices at the grocery store or pharmacy? In reality, many of the brands you think are competitors are actually owned by the same parent company. These corporate giants dominate entire industries, using multiple brand identities to give the illusion of variety. Once you understand… Grocery Coupon Guide · Jul 22, 2025
Stock Of The Day: Breakout In Johnson & Johnson Johnson Johnson (NYSE:JNJ) stalled out at resistance around the $165 level. There tends to be resistance at price levels that had previously been resistance. As you can see on the chart below, that's the case here. This level was also resistance in March. Benzinga · Jul 17, 2025
Want Steady Income? 3 Top Dividend Stocks for July 2025 Three dividend stocks stand out in July, offering reliable income, attractive yields, and strong fundamentals to help investors navigate market volatility MarketBeat · Jul 17, 2025
Johnson & Johnson Ups Forecast, Beats On EPS—But Wall Street Is Cautious Shares of Johnson Johnson (NYSE:JNJ) are under pressure Thursday, despite a strong second-quarter earnings report. Benzinga · Jul 17, 2025
Johnson & Johnson Analysts Raise Their Forecasts After Upbeat Earnings Johnson Johnson (NYSE:JNJ) posted better-than-expected quarterly earnings and raised its FY2025 earnings guidance on Wednesday. Benzinga · Jul 17, 2025
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78. The Nasdaq added 0.25% to finish at 20,730.49, while the SP 500 advanced 0.3% to 6,263.70. Benzinga · Jul 17, 2025
JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Johnson & Johnson is back in rally mode after years of post-pandemic normalization and the impact of repositioning, set up to sustain higher prices for years. MarketBeat · Jul 16, 2025
Benzinga · Jul 16, 2025 Johnson & Johnson Raises FY25 Forecast, Joins Rigetti Computing, Unity Software, Brighthouse Financial And Other Big Stocks Moving Higher On Wednesday U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Wednesday.
Benzinga · Jul 16, 2025 Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance Johnson Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68.
The Independent UK · Jul 15, 2025 Asian shares mostly decline as worries continue over Trump's tariffs Asian shares are trading mostly lower as worries about President Donald Trump’s latest updates to his tariffs weighed on investor sentiments
MarketBeat · Jul 14, 2025 These 3 Undervalued Stocks Could Surge as Value Rotation Nears A rotation back into value stocks may be imminent in today's market, giving investors a chance to expose themselves into a catch up play.
Grocery Coupon Guide · Jul 13, 2025 7 Shampoo Brands Facing Consumer Lawsuits Hair care should make you look better, not worse. Yet several major shampoo brands are now facing serious legal challenges from consumers who claim these products caused hair loss, scalp irritation, and other injuries. These lawsuits highlight growing concerns about potentially harmful ingredients in everyday hair care products.
Benzinga · Jul 11, 2025 Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Johnson Johnson (NYSE:JNJ) will release earnings results for the second quarter, before the opening bell on Wednesday, July 16.
Barchart · Jun 27, 2025 Here's What to Expect From Johnson & Johnson's Next Earnings Report Johnson & Johnson is set to unveil its Q2 results in the upcoming month, and analysts expect its profitability to observe a notable decline.
The Guardian - UK · Jun 8, 2025 Les Squires obituary Other lives: Non-woven fabrics designer who created new materials for use in industry and agriculture
MarketBeat · Jun 6, 2025 3 Top Dividend Stocks Analysts Are Bullish on Right Now With earnings season coming to an end, investors are looking for new catalysts; here are three blue-chip companies with strong analyst support
Barchart · May 29, 2025 Johnson & Johnson Stock: Is JNJ Outperforming the Healthcare Sector? Johnson & Johnson has outpaced the broader healthcare sector over the past year, and analysts remain optimistic about the stock’s prospects.
Barchart · May 28, 2025 Build a Bulletproof Dividend Portfolio With These 5 Defensive Stocks These defensive stocks pay reliable dividends.